Cytokinetics ticker

WebHistorical PS ratio values for Cytokinetics (CYTK) over the last 10 years. The current P/S ratio for Cytokinetics as of April 07, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. Compare CYTK With Other Stocks From: To: Zoom: 0 10 20 30 40 Stock Price 0 2 4 6 8 TTM Sales per Share WebBonnie Charpentier SVP Regulatory & Compliance at Cytokinetics, is currently unranked, see this insider's latest transactions. Top Stocks. Top Analyst Stocks Top Smart Score Stocks ... SVP Regulatory & Compliance at Cytokinetics, holds 0.00 shares in Cytokinetics (Ticker: CYTK). See the Hottest Stocks Based on Insider Trading > Bonnie ...

Cytokinetics Inc (CYTK) 8-K Earnings Release - Mar 2024

WebCytokinetics Incorporated 280 East Grand Avenue South San Francisco, CA 94080 United States. Website. Investor relation . Ratios; Stock Price Chart; Annual Returns; Financial … WebFeb 17, 2024 · It is currently -18.08% from its 52-week high and 51.01% from its 52-week low. How much is Cytokinetics stock worth today? ( NASDAQ: CYTK) Cytokinetics currently has 94,631,001 outstanding shares. With Cytokinetics stock trading at $45.71 per share, the total value of Cytokinetics stock (market capitalization) is $4.33B. solar battery for your home https://christophertorrez.com

Cytokinetics, Incorporated (NASDAQ:CYTK) Analysts Just Cut …

WebFeb 15, 2024 · SOUTH SAN FRANCISCO, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced topline results from METEORIC-HF ( M ulticenter E xercise T olerance E... WebCytokinetics is a biopharmaceutical company with a focus on the discovery, development, and commercialization of muscle activators and muscle inhibitors as potential treatments … WebApr 20, 2024 · Is CYTK stock a buy? Hedge fund interest in Cytokinetics, Inc. (NASDAQ: CYTK) shares was flat at the end of last quarter. This is usually a negative indicator. Our calculations also showed that... solar battery incentives australia

Cytokinetics: Contact Details and Business Profile - RocketReach

Category:Cytokinetics - AnnualReports.com

Tags:Cytokinetics ticker

Cytokinetics ticker

Cytokinetics Stock Price Today NASDAQ CYTK Live Ticker - Investing.com

WebDec 13, 2024 · PDUFA Target Action Date is February 28, 2024 Cytokinetics to Host Conference Call and Webcast on December 14, 2024 at 8:30 am Eastern Time SOUTH SAN FRANCISCO, Calif., Dec. 13, 2024 (GLOBE ... WebApr 7, 2024 · Cytokinetics, Inc.’s trailing 12-month revenue is $94.6 million with a -411.2% profit margin. Year-over-year quarterly sales growth most recently was -96.4%. Analysts expect adjusted earnings to reach $-4.363 per share for the current fiscal year. Cytokinetics, Inc. does not currently pay a dividend. The Biotechnology and Medical …

Cytokinetics ticker

Did you know?

WebJun 27, 2024 · CYTK has a market cap of $4.05bn and a cash balance of $686mn. Research and development expenses for the first quarter 2024 were $45.9 million, while general and administrative expenses were $33.1... WebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential …

WebFeb 28, 2024 · SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) issued a Complete... WebMar 1, 2024 · Cytokinetics Inc (CYTK) SEC Filing 8-K Material Event for the period ending Wednesday, March 1, 2024. Home. SEC Filings. Cytokinetics Inc (CYTK) 8-K Material Event Wed Mar 01 2024; SEC Filings. CYTK Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. Manager Portfolios.

Web2 days ago · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential … WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has …

WebTicker: CYTK; CUSIP Number: 23282w605; Tip: Access positions for across all investors ... By clicking the button below, your credit card will be charged $28.00 USD (one time) and you'll have access to all Cytokinetics position data for 90 days. Purchase access * Investors with a full data subscription can access data for any fund and any ticker ... solar battery installation regulationsWebNov 1, 2024 · SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on October 29, 2024 it granted stock options to purchase an aggregate... solar battery installer cabooltureWeb2 days ago · Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as … slumberland cream writing deskWebFeb 28, 2024 · The US FDA has issued a Complete Response Letter to Cytokinetics ( NASDAQ: CYTK) for omecamtiv mecarbil for heart failure with reduced ejection fraction. Shares are down ~8% in post-market trading ... solar battery inside or outsideWebApr 29, 2004 · Cytokinetics has raised a total of $1.1B in funding over 8 rounds. Their latest funding was raised on Jul 1, 2024 from a Post-IPO Debt round. Cytokinetics is … solar battery installers in essexWebApr 13, 2024 · Los analistas le han dado las siguientes calificaciones a AeroVironment (NASDAQ: AVAV) en el último trimestre: Según los 5 analistas que le han asignado precios objetivo de 12 meses en los últimos 3 meses, AeroVironment tiene un precio objetivo promedio de 116,00 dólares, con un máximo de 130,00 dólares y un mínimo de 105,00 … slumberland credit cardWebMar 4, 2024 · Today is shaping up negative for Cytokinetics, ... (ticker: BBBY) stock was down nearly 20% at 83 cents. In a reverse stock split, each outstanding share is converted into a fraction of the share. solar battery installation